10-Q: Ingevity Q3 Sees Profit Rebound Amid Divestiture, Tariff Headwinds

Ingevity Corporation reported a significant improvement in net income for Q3 2025, driven by reduced losses from discontinued operations, despite flat net sales and a downward revision to its full-year outlook.

Summary

• Net income for the three months ended September 30, 2025, was $43.5 million, a substantial improvement from a net loss of $107.2 million in the prior year quarter.
• Net income for the nine months ended September 30, 2025, was a loss of $82.5 million, significantly better than the $446.9 million loss in the same period of 2024.
• Net sales for continuing operations were flat at $333.1 million for the three months ended September 30, 2025, compared to $333.8 million in the prior year.
• Net sales for continuing operations decreased by 4% to $912.5 million for the nine months ended September 30, 2025, from $936.8 million in 2024.
• Adjusted EBITDA from continuing operations increased to $110.4 million for the three months and $302.8 million for the nine months ended September 30, 2025, up from $108.4 million and $296.7 million, respectively, in the prior year periods.
• The company entered into an Asset Purchase Agreement on September 3, 2025, to divest its industrial specialties product line and North Charleston crude tall oil refinery, expected to close by early 2026.
• A non-cash goodwill impairment charge of $183.8 million was recorded in the Advanced Polymer Technologies segment during Q2 2025 due to global trade tensions and increased consumer uncertainty.
• The full-year 2025 outlook for Net sales (inclusive of continuing and discontinued operations) was revised downwards to between $1.25 billion and $1.35 billion.
• Total Adjusted EBITDA (inclusive of continuing and discontinued operations) outlook for 2025 was revised to between $390 million and $405 million.
• The company repurchased $25.2 million of common stock, representing 445,724 shares at a weighted average cost of $56.09 per share, during the three and nine months ended September 30, 2025.
• Ingevity is appealing a jury verdict in the BASF lawsuit, which awarded BASF $85.0 million (trebled damages), with oral arguments scheduled for December 5, 2025. The company has accrued $94.4 million, including post-judgment interest, as of September 30, 2025.

Sentiment

Score: 5

Explanation: The sentiment is mixed. While the company showed significant improvement in overall net income due to reduced losses from discontinued operations and prior year impairments, continuing operations saw a slight decline in net income for the quarter. The downward revision of the full-year outlook for both net sales and total adjusted EBITDA, coupled with ongoing challenges in the Advanced Polymer Technologies segment and the significant legal liability from the BASF lawsuit, indicates persistent headwinds. However, the strategic divestiture and realized cost savings are positive steps towards long-term stability and profitability.

Positives

• Net income significantly improved to $43.5 million for the three months ended September 30, 2025, from a loss of $107.2 million in the prior year.
• Net loss for the nine months ended September 30, 2025, was reduced to $82.5 million from $446.9 million in the prior year, indicating a strong recovery trend.
• Adjusted EBITDA from continuing operations increased by $2.0 million (3 months) and $6.1 million (9 months) compared to the prior year periods.
• The Performance Chemicals segment saw a 4% increase in net sales and a 2% increase in Segment EBITDA for the three months ended September 30, 2025, driven by higher sales in North American pavement market.
• The divestiture of the industrial specialties product line and CTO Refinery is expected to improve profitability and reduce cyclicality for the company.
• Realized $103 million in cash savings from restructuring actions, including $82 million in Cost of sales, $16 million in Selling, general, and administrative expenses, and $5 million in Research and technical expenses.
• Realized an additional $12 million in lower full-year depreciation and intangible amortization expenses from restructuring.
• The company was in compliance with all debt covenants, including a net leverage ratio of 2.7 (vs. maximum 4.0) and an interest coverage ratio of 5.5 (vs. minimum 3.0) as of September 30, 2025.
• Cash provided by operating activities increased by $170.0 million to $234.1 million for the nine months ended September 30, 2025, driven by reduced CTO resale and termination cash outflows, and improved working capital management.

Negatives

• Net sales for continuing operations were flat for the three months and decreased by 4% for the nine months ended September 30, 2025, primarily due to volume declines.
• Net income from continuing operations decreased to $40.8 million for the three months ended September 30, 2025, from $47.5 million in the prior year.
• The Advanced Polymer Technologies segment experienced a 22% decrease in net sales for the three months and a 13% decrease for the nine months ended September 30, 2025, due to indirect tariff impacts, weak industrial demand, and increased competition in China.
• A non-cash goodwill impairment charge of $183.8 million was recorded in the Advanced Polymer Technologies segment during Q2 2025.
• The full-year 2025 outlook for Net sales and Total Adjusted EBITDA was revised downwards, reflecting continued pressure on the Advanced Polymer Technologies segment.
• The company faces a significant legal liability of $94.4 million (including interest) related to the BASF lawsuit, which has been reclassified to current liabilities, indicating an expected payout within the next twelve months.
• LIFO charges negatively impacted gross profit by $6.6 million for the three months and $16.2 million for the nine months ended September 30, 2025.
• Selling, general, and administrative expenses increased by $6.2 million (16%) for the three months and $10.1 million (8%) for the nine months ended September 30, 2025, primarily due to increased variable incentive compensation.

Risks

• The anticipated timing, charges, costs, and results of the Performance Chemicals segment repositioning, including the Divestiture, may differ materially from estimates.
• The Divestiture may not be consummated or may not yield the expected results or benefits.
• Risks are associated with co-located businesses following the Divestiture, including potential impacts to plant operations.
• The company may be adversely affected by general global economic, geopolitical, and financial conditions, including inflation, the Russia-Ukraine war, and the conflict in the Middle East.
• Exposure to risks related to international sales and operations, including changes in tariffs, which have negatively impacted the Advanced Polymer Technologies segment.
• Adverse conditions in the automotive market may continue to negatively impact demand for automotive carbon products.
• Competition from substitute products, new technologies, and new or emerging competitors.
• Lack of access to raw materials upon which the company depends would impact its ability to produce products.
• Dependence upon third parties for certain critical operating services at several facilities, including Mainstream Pine Products, LLC post-Divestiture.
• Disruptions in the supply chain could adversely affect the company.
• The occurrence of natural disasters, extreme weather, labor difficulties (including work stoppages), equipment failure, or unscheduled maintenance could result in operational disruptions.
• Dependence on attracting and retaining key personnel.
• Dependence on certain large customers.
• Ongoing legal actions associated with intellectual property rights, such as the BASF lawsuit, could result in significant financial liabilities.
• Inability to protect intellectual property and other proprietary information may lead to a loss of competitive advantage.
• Information technology security breaches and other disruptions.
• Government policies and regulations, including those affecting the environment, climate change, tax policies, tariffs, and the chemicals industry, may adversely affect financial results.
• Losses due to lawsuits arising out of environmental damage or personal injuries associated with chemical or other manufacturing processes.
• The ultimate realization of deferred tax assets depends on the generation of future taxable income, and a valuation allowance has been established for certain historical net operating losses and tax credits.

Future Outlook

Ingevity has revised its full-year 2025 outlook for Net sales (inclusive of both continuing and discontinued operations) to between $1.25 billion and $1.35 billion. Net sales in the Performance Materials segment are expected to be flat to slightly down, reflecting a projected 2% decline in North America light vehicle production. The Advanced Polymer Technologies segment's Net sales are anticipated to be down mid-teens due to continued indirect tariff impacts, weak industrial demand, and increased competition in China. The Performance Chemicals segment (inclusive of continuing and discontinued operations) is projected to generate full-year EBITDA margins in the high-single to low-double digits. The industrial specialties product line (now discontinued operations) is expected to deliver Net sales of around $130 million and an Adjusted EBITDA margin of approximately 6%, with indirect costs of about $15 million expected to be eliminated by the end of 2026. Total Adjusted EBITDA for 2025 (inclusive of both continuing and discontinued operations) has been revised to between $390 million and $405 million, reflecting ongoing pressures in the Advanced Polymer Technologies segment.

Management Comments

• Management believes the non-GAAP financial measures (Total Adjusted EBITDA, Adjusted EBITDA from continuing operations, and Adjusted EBITDA from discontinued operations) provide useful information to evaluate business performance and understand factors and trends affecting historical financial performance and projected future results, as they exclude the effects of financing, investment, and non-operating activities.
• Management considers the carrying value of variable interest rate debt, including the impact of a $200.0 million floating-to-fixed interest rate swap, to be a reasonable estimate of its fair value.
• Management believes that foreign holdings of cash will not have a material adverse impact on U.S. liquidity.

Industry Context

The filing highlights ongoing challenges from global trade tensions and international tariffs, particularly impacting the Advanced Polymer Technologies segment and leading to a goodwill impairment charge. Weak industrial demand and increased competition in China are also noted as headwinds. The Performance Materials segment is affected by a projected decline in North America light vehicle production. The strategic divestiture of the industrial specialties product line and CTO Refinery aims to reposition the Performance Chemicals segment, focusing on more profitable areas like road technologies and reducing exposure to cyclical, lower-margin markets. This move aligns with a broader industry trend of companies streamlining portfolios to enhance profitability and reduce volatility in a challenging global economic environment.

Corporate Governance

Legal Proceedings

• Ingevity is appealing a jury verdict from September 15, 2021, in the Delaware Proceeding, which awarded BASF approximately $85.0 million (trebled damages) for antitrust violations and tortious interference. The judgment was entered on May 18, 2023, and Ingevity appealed on March 13, 2024.
• Oral arguments on the appeals are scheduled for December 5, 2025, with final resolution expected within twelve months of the balance sheet date.
• The company has accrued $94.4 million as of September 30, 2025, inclusive of post-judgment interest, which has been reclassified to current liabilities, reflecting the expectation of final resolution within the next year. BASF may also seek attorneys' fees and costs.

Stakeholder Impact

• **Shareholders**: The divestiture aims to improve long-term profitability and reduce cyclicality, potentially enhancing shareholder value. However, the downward revision of the full-year outlook and the significant legal liability from the BASF lawsuit could negatively impact investor sentiment and share price in the short term. Share repurchases indicate a commitment to returning capital to shareholders.
• **Employees**: Restructuring actions have led to headcount reductions, contributing to realized cash savings. The divestiture will impact employees associated with the industrial specialties product line and CTO Refinery. Labor relations are ongoing, with new CBAs ratified at some plants and negotiations anticipated at others, which could affect employee stability.
• **Customers**: The repositioning of the Performance Chemicals segment focuses on growing profitable product lines like road technologies, potentially leading to improved service and product offerings in those areas. However, volume declines in Advanced Polymer Technologies due to tariffs and competition suggest challenges in meeting customer demand or maintaining market share in certain segments.
• **Suppliers**: The termination of the CTO supply contract and the divestiture of the CTO Refinery will alter supplier relationships for crude tall oil and related products. Disruptions to Mainstream Pine Products, LLC's operations post-divestiture could impact Ingevity's supply of Tall Oil Fatty Acid or other CTO derived products.
• **Creditors**: The company remains in compliance with all debt covenants, indicating sound financial management relative to its obligations. However, the reclassification of the BASF lawsuit liability to current liabilities highlights a significant near-term cash outflow risk.

Next Steps

• Close the Industrial Specialties Divestiture by early 2026.
• Eliminate approximately $15 million in indirect costs associated with the Divestiture by the end of 2026 through operational efficiencies and associated service agreements.
• Oral arguments on the BASF lawsuit appeals are scheduled for December 5, 2025, with final resolution expected within twelve months of the balance sheet date.
• Anticipate contract renewal negotiations for the CBA at the Covington, Virginia Plant with the Covington Paperworkers Union Local 675 during the fourth quarter of 2025.
• Continue to monitor evolving tax legislation in jurisdictions where the company operates, particularly regarding Pillar Two.

Key Dates

Recommendation

Ingevity's Q3 2025 results show a mixed picture. While the company achieved a significant turnaround in net income due to reduced losses from discontinued operations and realized substantial cost savings from restructuring, the core continuing operations experienced flat sales and a decline in net income for the quarter. The downward revision of the full-year outlook for both net sales and total adjusted EBITDA signals ongoing challenges, particularly in the Advanced Polymer Technologies segment due to tariffs and competition. The impending resolution of the $94.4 million BASF lawsuit, now a current liability, represents a material near-term cash outflow. The strategic divestiture is a positive long-term move to streamline the portfolio and reduce cyclicality, but its full benefits are yet to be realized. Given the combination of strategic positives, persistent operational headwinds, and a significant legal overhang, a 'hold' recommendation is appropriate. Investors should monitor the successful execution of the divestiture, the resolution of the BASF lawsuit, and the company's ability to navigate macroeconomic pressures and competitive dynamics in its continuing segments.

Keywords

Specialty Chemicals, Performance Materials, Advanced Polymer Technologies, Performance Chemicals, SEC Filing, 10-Q, Quarterly Report, Divestiture, Goodwill Impairment, Tariffs, Restructuring, BASF Lawsuit, Crude Tall Oil, CTO Refinery, Financial Results, EBITDA, Net Sales, Earnings Per Share, Capital Expenditures, Share Repurchase, Corporate Governance, Tax Reform